Cargando…

Health state utilities associated with attributes of treatments for hepatitis C

BACKGROUND: Cost-utility analyses are frequently conducted to compare treatments for hepatitis C, which are often associated with complex regimens and serious adverse events. Thus, the purpose of this study was to estimate the utility associated with treatment administration and adverse events of he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matza, Louis S., Sapra, Sandhya J., Dillon, John F., Kalsekar, Anupama, Davies, Evan W., Devine, Mary K., Jordan, Jessica B., Landrian, Amanda S., Feeny, David H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646927/ https://www.ncbi.nlm.nih.gov/pubmed/25481796 http://dx.doi.org/10.1007/s10198-014-0649-6

Ejemplares similares

Health state utilities associated with adult attention-deficit/hyperactivity disorder
por: Matza, Louis S, et al.
Publicado: (2014)

Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
por: Matza, Louis S., et al.
Publicado: (2017)

Acute and chronic impact of cardiovascular events on health state utilities
por: Matza, Louis S, et al.
Publicado: (2015)

Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions
por: Matza, Louis S, et al.
Publicado: (2014)

Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis
por: Davies, Evan W., et al.
Publicado: (2015)

Health state utilities associated with attributes of migraine preventive treatments based on patient and general population preferences
por: Matza, Louis S., et al.
Publicado: (2019)

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
por: Matza, Louis S, et al.
Publicado: (2018)

The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation
por: Matza, Louis S., et al.
Publicado: (2015)

A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes
por: Matza, Louis S., et al.
Publicado: (2015)

Health state utilities for skeletal-related events secondary to bone metastases
por: Matza, Louis S., et al.
Publicado: (2013)

A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)
por: Xie, Feng, et al.
Publicado: (2015)

Health state utilities associated with hyperphagia: Data for use in cost‐utility models
por: Howell, Timothy A., et al.
Publicado: (2023)

Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation
por: Matza, Louis S., et al.
Publicado: (2017)

Health state utilities associated with treatment for transfusion-dependent β-thalassemia
por: Matza, Louis S., et al.
Publicado: (2019)

Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV
por: Matza, Louis S., et al.
Publicado: (2022)

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017)

Ocular prodrugs: Attributes and challenges
por: kour, Jagpreet, et al.
Publicado: (2021)

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
por: Bennett, Hayley, et al.
Publicado: (2015)

Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C
por: McEwan, Phil, et al.
Publicado: (2015)

Preference for pharmaceutical formulation and treatment process attributes
por: Stewart, Katie D, et al.
Publicado: (2016)

Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy
por: Matza, Louis S., et al.
Publicado: (2019)

Societal perspectives on disease and treatment attributes characterizing rare diseases: a qualitative study from the United States
por: Szabo, Shelagh M., et al.
Publicado: (2022)

Health state utilities associated with post-surgical Staphylococcus aureus infections
por: Matza, Louis S., et al.
Publicado: (2019)

Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease
por: Briggs, Andrew H., et al.
Publicado: (2019)

Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma
por: Howell, Timothy A., et al.
Publicado: (2022)

Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes
por: Matza, Louis S., et al.
Publicado: (2021)

Incidence and cost of treatment-emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study
por: Sapra, Sandhya, et al.
Publicado: (2014)

Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review
por: Szabo, Shelagh M., et al.
Publicado: (2019)

The Health Utilities Index (HUI(®)): concepts, measurement properties and applications
por: Horsman, John, et al.
Publicado: (2003)

Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Matza, Louis S., et al.
Publicado: (2018)

Patient Perceptions of and Preferences Between Characteristics of Injectable Diabetes Treatments
por: Boye, Kristina S., et al.
Publicado: (2021)

Measurement properties of the Flu-Like Symptom Index from the Hepatitis Physical Symptom Severity Diary
por: Mathias, Susan, et al.
Publicado: (2013)

Comparing the health of low income and less well educated groups in the United States and Canada
por: Eng, Ken, et al.
Publicado: (2007)

Successful pilot application of multi-attribute utility analysis concepts in evaluating academic-clinical partnerships in the United States: a case report
por: North, Sara Elizabeth, et al.
Publicado: (2022)

Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in Japan
por: Sugimori, Hiroki, et al.
Publicado: (2022)

Development of a multiplicative, multi-attribute utility function and eight single-attribute utility functions for the Health Utilities Index Mark 3 in Japan
por: Noto, Shinichi, et al.
Publicado: (2020)

Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials
por: Di Tanna, Gian Luca, et al.
Publicado: (2019)

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
por: Nadkarni, Anagha, et al.
Publicado: (2013)

Qualitative analysis of patient-centered decision attributes associated with initiating hepatitis C treatment
por: Zuchowski, Jessica L., et al.
Publicado: (2015)

Assessing the relative and attributable risk of stressors to wetland condition across the conterminous United States
por: Herlihy, Alan T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jquefe18u3q91kl55r55cafrds